piggenome

Identification of Avramr1 from Phytophthorainfestans utilizing lengthy learn and cDNA

Posted on by Sarah

Identification of Avramr1 from Phytophthorainfestans using prolonged study and cDNA pathogen-enrichment sequencing (PenSeq)

Potato late blight, introduced on by the oomycete pathogen Phytophthorainfestans, significantly hampers potato manufacturing. Recently, a model new Resistance to Phytophthorainfestans (Rpi) gene, Rpi-amr1, was cloned from a wild Solanum species, Solanumamericanum.

 

Identification of the corresponding acknowledged effector (Avirulence or Avr) genes from P. infestans is crucial to elucidating their naturally occurring sequence variation, which in flip informs the potential sturdiness of the cognate late blight resistance. To ascertain the P. infestans effector acknowledged by Rpi-amr1, we screened obtainable RXLR effector libraries and used prolonged study and cDNA pathogen-enrichment sequencing (PenSeq) on Four P. infestans isolates to find the untested effectors.

 

Using single-molecule real-time sequencing (SMRT) and cDNA PenSeq, we acknowledged 47 extraordinarily expressed effectors from P. infestans, along with PITG_07569, which triggers a extraordinarily explicit cell lack of life response when transiently coexpressed with Rpi-amr1 in Nicotianabenthamiana, suggesting that PITG_07569 is Avramr1. Proper right here we show that prolonged study and cDNA PenSeq permits the identification of full-length RXLR effector households and their expression profile. This look at has revealed key insights into the evolution and polymorphism of a flowery RXLR effector family that is associated to the recognition by Rpi-amr1.

 

 

Orf Virus VEGF-E
MBS691891-5x0005mg 5x0.005mg
EUR 1275

Orf Virus VEGF-E
MBS691947-0002mg 0.002mg
EUR 265

Orf Virus VEGF-E
MBS691947-5x0002mg 5x0.002mg
EUR 890

VEGF E (Orf Virus)
cyt-263 2µg
EUR 60
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

Orf Virus VEGF-E, Heparin-binding
MBS691480-002mg 0.02mg
EUR 440

Orf Virus VEGF-E, Heparin-binding
MBS691480-5x002mg 5x0.02mg
EUR 1685

Orf Virus VEGF-E, Heparin-binding
MBS691994-0005mg 0.005mg
EUR 300

Orf Virus VEGF-E, Heparin-binding
MBS691994-5x0005mg 5x0.005mg
EUR 1050

Orf virus VEGF-E Recombinant Protein
300-044 5 µg
EUR 136.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein
300-044S 2 µg
EUR 73.5
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein
300-045 20 µg
EUR 357
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Anti-Orf Virus VEGF-E Antibody
102-PA70 50 µg
EUR 115.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg
QP10912-1mg 1mg
EUR 6181.2

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug
QP10912-2ug 2ug
EUR 186

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug
QP10912-10ug 10ug
EUR 241.2

Orf virus VEGF-E, Heparin-binding Recombinant Protein
300-046 20 µg
EUR 194.25
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf virus VEGF-E, Heparin-binding Recombinant Protein
300-046S 5 µg
EUR 94.5
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)
PROTQ2F842 Regular: 10ug
EUR 250
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

ov-VEGF-E (Orf virus) (Recombinant) Human
GWB-C8AD60 0.005 mg Ask for price

VEGFE protein (Orf virus)
30R-AV011 5 ug
EUR 381
Description: Purified recombinant VEGFE protein (Orf virus)

VEGFE protein (Orf virus)
MBS538323-0005mg 0.005mg
EUR 505

VEGFE protein (Orf virus)
MBS538323-5x0005mg 5x0.005mg
EUR 2125

Recombinant Orf Virus VEGFE Protein
VAng-Lsx0417-inquire inquire Ask for price
Description: Orf Virus VEGFE, recombinant protein from Baculovirus.

Recombinant Orf Virus VEGFE Protein [His]
VAng-Lsx0418-inquire inquire Ask for price
Description: Orf Virus VEGFE [His], recombinant protein from E. coli.

Cytochalasin E
C197-1MG 1 mg
EUR 79.77
Description: 36011-19-5

Cytochalasin E
C197-5MG 5 mg
EUR 276.58
Description: 36011-19-5

Chevalone E
C257-0.5MG 0.5 mg
EUR 153.46
Description: 1315451-94-5

Chevalone E
C257-2.5MG 2.5 mg
EUR 536.69
Description: 1315451-94-5

Berkeleylactone E
B087-1MG 1 mg
EUR 145.66
Description: 122211-62-5

Berkeleylactone E
B087-5MG 5 mg
EUR 509.81
Description: 122211-62-5

Deoxybrevianamide E
D083-1MG 1 mg
EUR 191.61
Description: 34610-68-9

Deoxybrevianamide E
D083-5MG 5 mg
EUR 670.21
Description: 34610-68-9

Oligomycin E
O021-1MG 1 mg
EUR 212.42
Description: 110231-34-0

Oligomycin E
O021-5MG 5 mg
EUR 741.31
Description: 110231-34-0

Paraherquamide E
P070-0.5MG 0.5 mg
EUR 271.38
Description: 125600-53-5

Paraherquamide E
P070-2.5MG 2.5 mg
EUR 947.66
Description: 125600-53-5

Phenelfamycin E
P078-1MG 1 mg
EUR 212.42
Description: 114451-31-9

Phenelfamycin E
P078-5MG 5 mg
EUR 741.31
Description: 114451-31-9

Roquefortine E
R035-1MG 1 mg
EUR 150
Description: 871982-52-4

Roquefortine E
R035-5MG 5 mg
EUR 524.55
Description: 871982-52-4

Azithromycin impurity E EvoPure®
A074-5MG 5 mg
EUR 605.18
Description: 612069-27-9

Hepatitis E virus ORF 3 Recombinant Protein
53-335 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-336 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-337 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-10mg 10 mg
EUR 325

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
20-abx263083
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 ug
  • 1 mg

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-25mg 25 mg
EUR 6500

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-5mg 5 mg
EUR 225

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)
MBS1007472-002mgBaculovirus 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)
MBS1007472-002mgEColi 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)
MBS1007472-002mgYeast 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)
MBS1007472-01mgEColi 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E)
MBS1007472-01mgYeast 0.1mg(Yeast)
EUR 870

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01759 2µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01760 10µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
7-01761 1mg Ask for price

Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant)
22060748-1 2 µg
EUR 190.94

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
cyt-263-10g 10µg
EUR 145

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
cyt-263-1mg 1mg
EUR 5100

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
cyt-263-2g 2µg
EUR 60

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
MBS142140-0002mg 0.002mg
EUR 240

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
MBS142140-001mg 0.01mg
EUR 310

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
MBS142140-1mg 1mg
EUR 5325

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)
MBS142140-5x1mg 5x1mg
EUR 23640

Vascular Endothelial Growth Factor-E Recombinant (Orf Virus)
rAP-2496 Inquiry Ask for price

Hepatitis E Virus ORF3 Protein
20-abx260138
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF3 Protein
abx260138-20g 20 µg
EUR 950

Hepatitis E Virus ORF3 Protein
abx260138-5g 5 µg
EUR 350

Hepatitis E virus
8942 100 ug
EUR 340
Description: ORF 2

Hepatitis E virus
8943 100 ug
EUR 340
Description: ORF 2

Hepatitis E virus
8944 100 ug
EUR 340
Description: ORF 3

Hepatitis E virus
MBS328020-01mg 0.1mg
EUR 435

Hepatitis E virus
MBS328020-5x01mg 5x0.1mg
EUR 1865

Hepatitis E virus
MBS328021-01mg 0.1mg
EUR 435

Hepatitis E virus
MBS328021-5x01mg 5x0.1mg
EUR 1865

Hepatitis E virus
MBS328022-01mg 0.1mg
EUR 435

Hepatitis E virus
MBS328022-5x01mg 5x0.1mg
EUR 1865

Hepatitis E virus
PCR-H498-PCRH49848R PCR-H498-48R
EUR 485

Hepatitis E virus
PCR-H498-PCRH49896R PCR-H498-96R
EUR 685

Hepatitis E virus
Oneq-H498-OneqH498100R Oneq-H498-100R
EUR 1028

Hepatitis E virus
Oneq-H498-OneqH498150R Oneq-H498-150R
EUR 1438

Hepatitis E virus
Oneq-H498-OneqH49850R Oneq-H498-50R
EUR 728

Recombinant Hepatitis E Virus ORF3 
7-07450 100µg Ask for price

Recombinant Hepatitis E Virus ORF3 
7-07451 500µg Ask for price

Recombinant Hepatitis E Virus ORF3 
7-07452 1000µg Ask for price

Hepatitis E Virus ORF3 (Recombinant)
22060181-1 100 µg
EUR 344.89

Recombinant Hepatitis E Virus ORF3 
MBS142588-01mg 0.1mg
EUR 330

Recombinant Hepatitis E Virus ORF3 
MBS142588-05mg 0.5mg
EUR 825

Recombinant Hepatitis E Virus ORF3 
MBS142588-1mg 1mg
EUR 1515

Recombinant Hepatitis E Virus ORF3 
MBS142588-5x1mg 5x1mg
EUR 6485

Hepatitis E Virus ORF3 Recombinant
rAP-5321 Inquiry Ask for price

Hepatitis E Virus, ORF2, Recombinant (HEV)
MBS637880-01mg 0.1mg
EUR 455

Hepatitis E Virus, ORF2, Recombinant (HEV)
MBS637880-05mg 0.5mg
EUR 1025

Hepatitis E Virus, ORF2, Recombinant (HEV)
MBS637880-5x05mg 5x0.5mg
EUR 4470

Hepatitis E Virus, ORF3, Recombinant (HEV)
MBS636730-01mg 0.1mg
EUR 735

Hepatitis E Virus, ORF3, Recombinant (HEV)
MBS636730-5x01mg 5x0.1mg
EUR 3155

VEGF (165): Human Recombinant E Coli
GWB-BDEFEF 1 mg Ask for price

OPPA00528-2UG - VEGF E Protein
OPPA00528-2UG 2ug
EUR 70

Hepatitis E Virus ORF2 (452-617) Protein
20-abx260268
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (452-617) Protein
abx260268-20g 20 µg
EUR 950

Hepatitis E Virus ORF2 (452-617) Protein
abx260268-5g 5 µg
EUR 350

Hepatitis E Virus ORF2 (633-659) Protein
20-abx260269
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (633-659) Protein
abx260269-25g 25 µg
EUR 950

Hepatitis E Virus ORF2 (633-659) Protein
abx260269-5g 5 µg
EUR 350

Hepatitis E Virus ORF2 (403-461) Protein
20-abx260270
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF2 (403-461) Protein
abx260270-25g 25 µg
EUR 950

Hepatitis E Virus ORF2 (403-461) Protein
abx260270-5g 5 µg
EUR 350

Hepatitis E virus (ratHEV)
PCR-V372-PCRV37248R PCR-V372-48R
EUR 485

Hepatitis E virus (ratHEV)
PCR-V372-PCRV37296R PCR-V372-96R
EUR 685

Hepatitis E virus (ratHEV)
Oneq-V372-OneqV372100R Oneq-V372-100R
EUR 1028

Hepatitis E virus (ratHEV)
Oneq-V372-OneqV372150R Oneq-V372-150R
EUR 1438

Hepatitis E virus (ratHEV)
Oneq-V372-OneqV37250R Oneq-V372-50R
EUR 728

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)
MBS1215198-002mgBaculovirus 0.02mg(Baculovirus)
EUR 995

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)
MBS1215198-002mgEColi 0.02mg(E-Coli)
EUR 560

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)
MBS1215198-002mgYeast 0.02mg(Yeast)
EUR 750

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)
MBS1215198-01mgEColi 0.1mg(E-Coli)
EUR 670

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF A)
MBS1215198-01mgYeast 0.1mg(Yeast)
EUR 875

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)
MBS1205850-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1005

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)
MBS1205850-002mgEColi 0.02mg(E-Coli)
EUR 570

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)
MBS1205850-002mgYeast 0.02mg(Yeast)
EUR 755

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)
MBS1205850-01mgEColi 0.1mg(E-Coli)
EUR 680

Recombinant Vaccinia virus Uncharacterized 9.3 kDa protein (D ORF E)
MBS1205850-01mgYeast 0.1mg(Yeast)
EUR 885

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)
MBS1182981-002mgBaculovirus 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)
MBS1182981-002mgEColi 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)
MBS1182981-002mgYeast 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)
MBS1182981-01mgEColi 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF D)
MBS1182981-01mgYeast 0.1mg(Yeast)
EUR 870

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)
MBS1177237-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1015

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)
MBS1177237-002mgEColi 0.02mg(E-Coli)
EUR 585

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)
MBS1177237-002mgYeast 0.02mg(Yeast)
EUR 770

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)
MBS1177237-01mgEColi 0.1mg(E-Coli)
EUR 700

Recombinant Vaccinia virus Uncharacterized 10.5 kDa protein (B ORF E)
MBS1177237-01mgYeast 0.1mg(Yeast)
EUR 900

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)
MBS1122067-002mgBaculovirus 0.02mg(Baculovirus)
EUR 990

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)
MBS1122067-002mgEColi 0.02mg(E-Coli)
EUR 555

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)
MBS1122067-002mgYeast 0.02mg(Yeast)
EUR 745

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)
MBS1122067-01mgEColi 0.1mg(E-Coli)
EUR 660

Recombinant Vaccinia virus Uncharacterized 7.2 kDa protein (C ORF E)
MBS1122067-01mgYeast 0.1mg(Yeast)
EUR 870

Recombinant Vaccinia virus Uncharacterized 7.8 kDa protein (F ORF E)
MBS1252431-002mgBaculovirus 0.02mg(Baculovirus)
EUR 995

 

Rat Cholesterol ELISA ELISA
E01A11128
Rat Cholesterol ELISA ELISA
E02C0745-48wellsplate
Rat Cholesterol ELISA ELISA
E02C0745-96wellsplate

 

Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31:

As a novel enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) warrants additional investigation. On this examine, a Chinese language PDCoV pressure, designated CHN-HN-1601, was remoted from the feces of a diarrheic piglet. After plaque purification, the genome was decided which shared 97.5%-99.5% nucleotide identities with 71 consultant PDCoV strains obtainable within the GenBank. The pathogenic properties of CHN-HN-1601 have been evaluated utilizing 5-day-old piglets.
All inoculated piglets developed extreme diarrhea from 2 days post-infection (dpi) onwards. To our shock, two intervals of diarrhea ranging from 2 to 7 dpi and from 13 to 19 dpi have been noticed in affected piglets in the course of the experiment. Fecal viral shedding of the inoculated piglets was detected by real-time RT-PCR, with viral shedding peaked at Four and 16 dpi, respectively. At necropsy at 5 dpi, the primary gross lesions included clear, thin-walled and gas-distended intestines containing yellow watery contents.
Additional histopathological examinations, together with hematoxylin and eosin staining, immunohistochemistry, RNAscope in situ hybridization revealed that the virus an infection prompted extreme villous atrophy of the small intestines, with PDCoV antigen and RNA primarily distributed within the cytoplasm of the villous epithelial cells of jejunum and ileum in piglets.
The dynamic manufacturing of PDCoV-specific IgG and neutralizing antibodies in serum of the affected piglets was additionally assessed utilizing a complete virus-based ELISA and an immunofluorescence assay-based neutralization take a look at, respectively. Moreover, a full-length cDNA infectious clone of CHN-HN-1601 was constructed utilizing a bacterial synthetic chromosome system.
The rescued virus exhibited in vitro progress and pathogenic properties just like the parental virus. Taken collectively, our examine not solely enriches the knowledge of PDCoV, but in addition offers a helpful reverse genetics platform for additional pathogenesis exploration of the virus.

metabolism

 

Aim: Uridine diphospho-glucuronosyltransferases (UGTs) are membrane-bound enzymes that catalyze the conjugation of glucuronic acid onto a varied set of xenobiotics. Horses successfully and extensively glucuronidate numerous xenobiotics, along with opioids, making UGTs an very important group of drug-metabolizing enzymes for the clearance of remedy. Recombinant enzymes have allowed researchers to characterize the metabolism of a variety of remedy. The primary objective was to clone, particular and characterize equine UGTs using remedy characterised as UGT substrates in several species. A secondary objective was to characterize the in vitro metabolism of morphine in horses.

 

Study design: In vitro drug metabolism look at using liver microsomes and recombinant enzyme strategies.

 

Animals: Liver microsomes and RNA from tissue collected from two Thoroughbred mares euthanized for various causes.

 

Methods: Based totally on homology to the human UGT2B7, Four equine UGT variants have been expressed: UGT1A1, UGT2A1, UGT2B31 and UGT2B4. cDNA sequences have been cloned and ensuing protein expressed in a baculovirus expression system. Efficiency of the enzymes was assessed using 4-methylumbelliferone, testosterone, diclofenac and ketoprofen. Recombinant enzyme, administration cells, equine liver microsomes and human UGT2B7 supersomes have been then incubated with morphine. Concentrations of metabolites have been measured using liquid chromatography-tandem mass spectrometry and enzyme kinetics determined.

 

Outcomes: 4-Methylumbelliferone was glucuronidated by all expressed equine UGTs. Testosterone glucuronide was not produced by any of the expressed enzymes, and diclofenac glucuronide and ketoprofen glucuronide have been produced by UG2A1 and UGT1A1, respectively. UGT2B31 metabolized morphine to morphine-3-glucuronide and low concentrations of morphine-6-glucuronide.

 

Conclusions and scientific relevance: That’s the major worthwhile expression of helpful recombinant equine UGTs. UGT2B31 contributes to the glucuronidation of morphine; nonetheless, it is most likely not the first metabolizing enzyme. These outcomes warrant further investigation of equine UGTs, along with expression of additional enzymes and extra characterization of UGT2B31 as a contributor to morphine metabolism.

 

An progressive genosensor for the monitoring of Leishmaniaspp sequence using binding of pDNA to cDNA based totally on Cit-AgNPs

 

Leishmaniasis regarded as basically probably the most important epidemic-prone diseases based mostly on the World Nicely being Group. Early diagnoses and treatment of Leishmania an an infection is an efficient downside since, it has no symptom and is resistance to remedy. Subsequently, there’s an urgent need for delicate and precise detection of this pathogen.

 

On this look at, a model new approach was developed for optical biosensing of Leishmaniaspp sequence based totally on hybridization of Citrate capped Ag nanoparticles bonded to explicit single stranded DNA probe of Leishmania spp. Aggregation of the Citrate capped Ag nanoparticles inside the existence or lack of a cDNA sequence of Leishmania, set off eye catching and considerable very important alter inside the UV-vis.

 

The obtained low prohibit of quantification (LLOQ) of was achieved as 1ZM. Based totally on experimental ends in optimum conditions, quick bioanalysis of Leishmaniaspp sequence was carried out (2 min). So, this probe may be utilized for the scientific evaluation of this pathogen and an an infection sickness.

 

Paraffin Wax
P191410
Paraffin wax pellets
GRM10702-2KG
Paraffin wax pellets
GRM10702-500G
Paraffin wax Pellets
GRM10702W-2KG
Paraffin wax Pellets
GRM10702W-500G

Improvement of a Full-Size Infectious Cdna Clone of the Grapevine Berry Inside Necrosis Virus

Grapevine berry interior necrosis virus (GINV) belongs to the genus Trichovirus within the household Betaflexiviridae. The GINV isolate LN_BETA_RS was obtained from a “Beta” grapevine (Vitis riparia × Vitis labrusca) exhibiting chlorotic mottling and ring spot in Xingcheng, Liaoning Province, China. To confirm the correlation between GINV and grapevine chlorotic mottling and ring spot illness, we constructed an infectious cDNA clone of GINV isolate LN_BETA_RS utilizing the seamless meeting strategy.
Utilized remedies of agroinfiltration infectious cDNA confirmed systemic GINV an infection of the Nicotianaoccidentalis 37B by reverse transcription polymerase chain response (RT-PCR) and transmission electron microscopy, exhibiting chlorotic mottling signs on leaves. Infectious cDNA was additionally transmitted to new wholesome N. occidentalis crops via rub-inoculation. Furthermore, the cDNA clone was agroinfiltrated into “Beta” and “Thompson Seedless” grapevine plantlets, and the inoculated grapevines exhibited leaf chlorotic mottling and ringspot in the course of the two years of statement.
GINV-inoculated “Beta” grapevines had severe leaf chlorotic mottling and ringspot signs on the entire plant, whereas comparatively few signs have been noticed on the leaves of agroinoculated “Thompson Seedless” grapevines in early spring and solely weak ring spot progressively appeared later within the prime younger leaves. Our experiments fulfilled Koch’s postulates and revealed the causative position of GINV in grapevine chlorotic mottling and ring spot illness.
Rat Cholesterol ELISA ELISA
E01A11128
Rat Cholesterol ELISA ELISA
E02C0745-48wellsplate
Rat Cholesterol ELISA ELISA
E02C0745-96wellsplate

A pressure of porcine deltacoronavirus: genomic characterization, pathogenicity and its full-length cDNA infectious clone

 

As a novel enteropathogenic coronavirus, porcine deltacoronavirus (PDCoV) warrants additional investigation. On this examine, a Chinese language PDCoV pressure, designated CHN-HN-1601, was remoted from the feces of a diarrheic piglet. After plaque purification, the genome was decided which shared 97.5%-99.5% nucleotide identities with 71 consultant PDCoV strains obtainable within the GenBank.
The pathogenic properties of CHN-HN-1601 have been evaluated utilizing 5-day-old piglets. All inoculated piglets developed extreme diarrhea from 2 days post-infection (dpi) onwards. To our shock, two intervals of diarrhea ranging from 2 to 7 dpi and from 13 to 19 dpi have been noticed in affected piglets in the course of the experiment. Fecal viral shedding of the inoculated piglets was detected by real-time RT-PCR, with viral shedding peaked at Four and 16 dpi, respectively. At necropsy at 5 dpi, the primary gross lesions included clear, thin-walled and gas-distended intestines containing yellow watery contents.
Additional histopathological examinations, together with hematoxylin and eosin staining, immunohistochemistry, RNAscope in situ hybridization revealed that the virus an infection prompted extreme villous atrophy of the small intestines, with PDCoV antigen and RNA primarily distributed within the cytoplasm of the villous epithelial cells of jejunum and ileum in piglets. The dynamic manufacturing of PDCoV-specific IgG and neutralizing antibodies in serum of the affected piglets was additionally assessed utilizing a complete virus-based ELISA and an immunofluorescence assay-based neutralization take a look at, respectively.
Moreover, a full-length cDNA infectious clone of CHN-HN-1601 was constructed utilizing a bacterial synthetic chromosome system. The rescued virus exhibited in vitro progress and pathogenic properties just like the parental virus. Taken collectively, our examine not solely enriches the knowledge of PDCoV, but in addition offers a helpful reverse genetics platform for additional pathogenesis exploration of the virus.

VEGFE protein (Orf virus)
MBS538323-0005mg 0.005mg
EUR 505

VEGFE protein (Orf virus)
MBS538323-5x0005mg 5x0.005mg
EUR 2125

Recombinant Orf Virus VEGFE Protein
VAng-Lsx0417-inquire inquire Ask for price
Description: Orf Virus VEGFE, recombinant protein from Baculovirus.

Recombinant Orf Virus VEGFE Protein [His]
VAng-Lsx0418-inquire inquire Ask for price
Description: Orf Virus VEGFE [His], recombinant protein from E. coli.

Orf virus VEGF-E Recombinant Protein
300-044 5 µg
EUR 136.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein
300-044S 2 µg
EUR 73.5
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E Recombinant Protein
300-045 20 µg
EUR 357
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Orf virus VEGF-E, Heparin-binding Recombinant Protein
300-046 20 µg
EUR 194.25
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf virus VEGF-E, Heparin-binding Recombinant Protein
300-046S 5 µg
EUR 94.5
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1.

Orf Virus VEGF-E
MBS691797-002mg 0.02mg
EUR 695

Orf Virus VEGF-E
MBS691797-5x002mg 5x0.02mg
EUR 2830

Orf Virus VEGF-E
MBS691891-0005mg 0.005mg
EUR 350

Orf Virus VEGF-E
MBS691891-5x0005mg 5x0.005mg
EUR 1275

Orf Virus VEGF-E
MBS691947-0002mg 0.002mg
EUR 265

Orf Virus VEGF-E
MBS691947-5x0002mg 5x0.002mg
EUR 890

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)
PROTQ2F842 Regular: 10ug
EUR 250
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

Orf Virus VEGF-E, Heparin-binding
MBS691480-002mg 0.02mg
EUR 440

Orf Virus VEGF-E, Heparin-binding
MBS691480-5x002mg 5x0.02mg
EUR 1685

Orf Virus VEGF-E, Heparin-binding
MBS691994-0005mg 0.005mg
EUR 300

Orf Virus VEGF-E, Heparin-binding
MBS691994-5x0005mg 5x0.005mg
EUR 1050

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg
QP10912-1mg 1mg
EUR 6181.2

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug
QP10912-2ug 2ug
EUR 186

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug
QP10912-10ug 10ug
EUR 241.2

Anti-Orf Virus VEGF-E Antibody
102-PA70 50 µg
EUR 115.5
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR.

Human PDGFC / VEGFE, Fc Tag
E24PHA208 50 μg
EUR 180

Human PDGFC / VEGFE, His Tag
E24PHA209 50 μg
EUR 225

VEGF E (Orf Virus)
cyt-263 2µg
EUR 60
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

Cynomolgus / Rhesus Macaque PDGFC / VEGFE, Fc Tag
E24PCA081 50 μg
EUR 180

Cynomolgus / Rhesus Macaque PDGFC / VEGFE, His Tag
E24PCA082 50 μg
EUR 225

Recombinant Orf virus 10 kDa fusion protein
MBS1129089-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1015

Recombinant Orf virus 10 kDa fusion protein
MBS1129089-002mgEColi 0.02mg(E-Coli)
EUR 580

Recombinant Orf virus 10 kDa fusion protein
MBS1129089-002mgYeast 0.02mg(Yeast)
EUR 765

Recombinant Orf virus 10 kDa fusion protein
MBS1129089-01mgEColi 0.1mg(E-Coli)
EUR 695

Recombinant Orf virus 10 kDa fusion protein
MBS1129089-01mgYeast 0.1mg(Yeast)
EUR 895

Recombinant Orf virus Protein F9 homolog (A3R)
MBS1202811-INQUIRE INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R)
MBS1072246-INQUIRE INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038987-002mg 0.02mg
EUR 1335

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038987-01mg 0.1mg
EUR 2300

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038987-5x01mg 5x0.1mg
EUR 10300

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038988-002mg 0.02mg
EUR 1330

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038988-01mg 0.1mg
EUR 2295

Recombinant Orf virus Protein F9 homolog (A3R)
MBS7038988-5x01mg 5x0.1mg
EUR 10295

Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics anti-PDGF-C)
E24CHA317 100 μg
EUR 225
Description: Available in various conjugation types.

Hepatitis E virus ORF 3 Recombinant Protein
53-335 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-336 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein
53-337 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Recombinant Orf virus Protein F9 homolog (A3R), partial
MBS7061474-INQUIRE INQUIRE Ask for price

Recombinant Orf virus Protein F9 homolog (A3R), partial
MBS7061495-INQUIRE INQUIRE Ask for price

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-10mg 10 mg
EUR 325

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
20-abx263083
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 ug
  • 1 mg

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-25mg 25 mg
EUR 6500

Vascular Endothelial Growth Factor-E (Orf Virus) Protein
abx263083-5mg 5 mg
EUR 225

Recombinant Figwort mosaic virus Movement protein (ORF I)
MBS1050972-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1200

Recombinant Figwort mosaic virus Movement protein (ORF I)
MBS1050972-002mgEColi 0.02mg(E-Coli)
EUR 850

Recombinant Figwort mosaic virus Movement protein (ORF I)
MBS1050972-002mgYeast 0.02mg(Yeast)
EUR 990

Recombinant Figwort mosaic virus Movement protein (ORF I)
MBS1050972-01mgEColi 0.1mg(E-Coli)
EUR 1020

Recombinant Figwort mosaic virus Movement protein (ORF I)
MBS1050972-01mgYeast 0.1mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1235484-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1235484-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1235484-002mgYeast 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1235484-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1235484-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1131598-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1131598-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1131598-002mgYeast 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1131598-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1131598-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1250494-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1250494-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1250494-002mgYeast 0.02mg(Yeast)
EUR 1115

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1250494-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1250494-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1007636-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1007636-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1007636-002mgYeast 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1007636-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1007636-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1092759-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1092759-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1092759-002mgYeast 0.02mg(Yeast)
EUR 1125

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1092759-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Cauliflower mosaic virus Capsid protein (ORF IV)
MBS1092759-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)
MBS1432961-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1045

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)
MBS1432961-002mgEColi 0.02mg(E-Coli)
EUR 620

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)
MBS1432961-002mgYeast 0.02mg(Yeast)
EUR 795

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)
MBS1432961-01mgEColi 0.1mg(E-Coli)
EUR 720

Recombinant Walleye dermal sarcoma virus Protein ORF-C (orfC)
MBS1432961-01mgYeast 0.1mg(Yeast)
EUR 930

Virus Measles Virus (MeV) Protein
abx670263-1ml 1 ml
EUR 543.6

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1184457-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1184457-002mgEColi 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1184457-002mgYeast 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1184457-01mgEColi 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1184457-01mgYeast 0.1mg(Yeast)
EUR 1130

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1033786-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1033786-002mgEColi 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1033786-002mgYeast 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1033786-01mgEColi 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1033786-01mgYeast 0.1mg(Yeast)
EUR 1130

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1093694-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1205

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1093694-002mgEColi 0.02mg(E-Coli)
EUR 855

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1093694-002mgYeast 0.02mg(Yeast)
EUR 995

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1093694-01mgEColi 0.1mg(E-Coli)
EUR 1030

Recombinant Cauliflower mosaic virus Movement protein (ORF I)
MBS1093694-01mgYeast 0.1mg(Yeast)
EUR 1130

Recombinant Walleye dermal sarcoma virus ORF-B protein
MBS7041397-002mg 0.02mg
EUR 1615

Recombinant Walleye dermal sarcoma virus ORF-B protein
MBS7041397-01mg 0.1mg
EUR 2570

Recombinant Walleye dermal sarcoma virus ORF-B protein
MBS7041397-5x01mg 5x0.1mg
EUR 11530

Virus West Nile Virus (WNV) Protein
abx670276-100ug 100 ug
EUR 794.4

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)
MBS1130671-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1355

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)
MBS1130671-002mgEColi 0.02mg(E-Coli)
EUR 1055

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)
MBS1130671-002mgYeast 0.02mg(Yeast)
EUR 1125

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)
MBS1130671-01mgEColi 0.1mg(E-Coli)
EUR 1230

Recombinant Figwort mosaic virus Probable capsid protein (ORF IV)
MBS1130671-01mgYeast 0.1mg(Yeast)
EUR 1310

Recombinant Carnation etched ring virus Movement protein (ORF I)
MBS1056689-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1195

Recombinant Carnation etched ring virus Movement protein (ORF I)
MBS1056689-002mgEColi 0.02mg(E-Coli)
EUR 845

Recombinant Carnation etched ring virus Movement protein (ORF I)
MBS1056689-002mgYeast 0.02mg(Yeast)
EUR 985

Recombinant Carnation etched ring virus Movement protein (ORF I)
MBS1056689-01mgEColi 0.1mg(E-Coli)
EUR 1015

Recombinant Carnation etched ring virus Movement protein (ORF I)
MBS1056689-01mgYeast 0.1mg(Yeast)
EUR 1125

Virus Hepatitis A Virus (HAV) Protein
abx670259-1ml 1 ml
EUR 427.2

Virus Yellow Fever Virus (YFV) Protein
abx670277-100ug 100 ug
EUR 644.4

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)
MBS1213579-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1040

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)
MBS1213579-002mgEColi 0.02mg(E-Coli)
EUR 615

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)
MBS1213579-002mgYeast 0.02mg(Yeast)
EUR 790

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)
MBS1213579-01mgEColi 0.1mg(E-Coli)
EUR 715

Recombinant Figwort mosaic virus Virion-associated protein (ORF III)
MBS1213579-01mgYeast 0.1mg(Yeast)
EUR 925

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)
MBS1057844-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1085

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)
MBS1057844-002mgEColi 0.02mg(E-Coli)
EUR 675

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)
MBS1057844-002mgYeast 0.02mg(Yeast)
EUR 840

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)
MBS1057844-01mgEColi 0.1mg(E-Coli)
EUR 785

Recombinant Figwort mosaic virus Aphid transmission protein (ORF II)
MBS1057844-01mgYeast 0.1mg(Yeast)
EUR 980

Virus Varicella Zoster Virus (VZV) Protein
abx670269-1ml 1 ml
EUR 794.4

Hepatitis E Virus ORF3 Protein
20-abx260138
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Hepatitis E Virus ORF3 Protein
abx260138-20g 20 µg
EUR 950

Hepatitis E Virus ORF3 Protein
abx260138-5g 5 µg
EUR 350

Recombinant Walleye dermal sarcoma virus ORF-B protein, partial
MBS7091428-INQUIRE INQUIRE Ask for price

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1149572-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1149572-002mgEColi 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1149572-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1149572-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1149572-01mgYeast 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1261084-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1261084-002mgEColi 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1261084-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1261084-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1261084-01mgYeast 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1053151-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1053151-002mgEColi 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1053151-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1053151-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1053151-01mgYeast 0.1mg(Yeast)
EUR 940

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1013968-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1050

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1013968-002mgEColi 0.02mg(E-Coli)
EUR 630

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1013968-002mgYeast 0.02mg(Yeast)
EUR 805

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1013968-01mgEColi 0.1mg(E-Coli)
EUR 735

Recombinant Cauliflower mosaic virus Virion-associated protein (ORF III)
MBS1013968-01mgYeast 0.1mg(Yeast)
EUR 940

Virus Respiratory Syncytial Virus (RSV) Protein
abx670078-01mg 0.1 mg
EUR 594

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1125301-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1125301-002mgEColi 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1125301-002mgYeast 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1125301-01mgEColi 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1125301-01mgYeast 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1236167-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1236167-002mgEColi 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1236167-002mgYeast 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1236167-01mgEColi 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1236167-01mgYeast 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1208165-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1020

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1208165-002mgEColi 0.02mg(E-Coli)
EUR 595

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1208165-002mgYeast 0.02mg(Yeast)
EUR 775

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1208165-01mgEColi 0.1mg(E-Coli)
EUR 690

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1208165-01mgYeast 0.1mg(Yeast)
EUR 910

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1161869-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1161869-002mgEColi 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1161869-002mgYeast 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1161869-01mgEColi 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1161869-01mgYeast 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1255499-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1255499-002mgEColi 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1255499-002mgYeast 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1255499-01mgEColi 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1255499-01mgYeast 0.1mg(Yeast)
EUR 975

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1029118-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1080

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1029118-002mgEColi 0.02mg(E-Coli)
EUR 670

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1029118-002mgYeast 0.02mg(Yeast)
EUR 835

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1029118-01mgEColi 0.1mg(E-Coli)
EUR 780

Recombinant Cauliflower mosaic virus Aphid transmission protein (ORF II)
MBS1029118-01mgYeast 0.1mg(Yeast)
EUR 975

Varicella Zoster Virus ORF26 Protein
20-abx260176
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Varicella Zoster Virus ORF26 Protein
abx260176-20g 20 µg
EUR 950

 

Source :

  1. Gentaur
  2. NCBI

Leave a Reply

Your email address will not be published.